Search Medical Condition
Please enter condition
Please choose location from dropdown

Etobicoke,, Canada Clinical Trials

A listing of Etobicoke,, Canada clinical trials actively recruiting patients volunteers.

RESULTS

Found (1368) clinical trials

Escitalopram for Agitation in Alzheimer's Disease

This study is designed to examine the efficacy and safety of escitalopram as treatment for agitation in Alzheimer's dementia (AD) patients. Participants with clinically significant agitation, and their caregiver(s), will receive a structured psychosocial intervention. Participants not showing a response three weeks later will be randomized 1:1 to escitalopram (up ...

Phase

5.04 miles

Learn More »

A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse

This is a multicenter, open-label, 2-arm, randomized trial with a pragmatic design involving 276 individuals with prescription opioid use disorder. Participants will be randomized to receive either: Methadone provided via initial daily witnessed ingestion as per local guidelines. Buprenorphine/naloxone maintenance therapy provided via flexible take-home dose regimens dispensed as per ...

Phase

5.04 miles

Learn More »

MARt-Depression Trial

Home-based tDCS-cCBT will involve 30-min tDCS (3 days per week) for the first 3 months and once weekly for the subsequent 3 months, in combination with computerized CBT delivered through an online portal for the duration of tDCS each day. Subjects who miss 4 consecutive treatment days or 20 percent ...

Phase N/A

5.04 miles

Learn More »

Efficacy of Convulsive Therapies for Bipolar Depression

The study will involve a randomized, double blind, non-inferiority clinical trial with two treatment arms conducted in three academic institutions (the Centre for Addiction and Mental Health (CAMH) in Toronto, Ontario; the Parkwood Institute in London, Ontario; and University of British Columbia (UBC) Hospital in Vancouver, British Columbia). The investigators ...

Phase N/A

5.04 miles

Learn More »

Cognitive Remediation in Late-Life Schizophrenia

Thirty late life schizophrenia (LLS) participants, age 55 and over, will undergo the CR intervention after completion of the baseline assessments. CR is a group-based psychotherapy that will consist of two, 2-hour weekly therapist-guided classes over 12 weeks, with a half-hour lunch break. The 24 classes are divided into two ...

Phase N/A

5.04 miles

Learn More »

rTMS and Cognitive Training in Youth Depression

Youth depression affects roughly 10% of the North American population, effecting high costs to both individuals and society at large. Unfortunately, few effective treatments exist. Antidepressant medications such as selective serotonergic reuptake inhibitors (SSRIs) are associated with side effects, and possess marginal efficacy in this age group. Black box warnings ...

Phase N/A

5.04 miles

Learn More »

Efficacy of Convulsive Therapies During Continuation

The study will involve a parallel-group clinical trial with three treatment arms conducted at the Centre for Addiction and Mental Health (CAMH) in Toronto, ON, Parkwood Institute of St. Joseph's Healthcare in London, ON and University of British Columbia (UBC) Hospital in Vancouver, BC. It will include participants who are ...

Phase N/A

5.04 miles

Learn More »

Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia

This project will take place in 7 sites across two settings: Inpatient (CAMH in Toronto, Douglas Hospital Research Centre in Montreal, Parkwood Institute in London, and the University of Calgary in Calgary); and LTCFs affiliated with CAMH in Toronto and Parkwood Institute in London. After a project initiation phase of ...

Phase N/A

5.04 miles

Learn More »

ERG Components in Schizophrenia and Bipolar Disorder Type I

The technology under development by diaMentis is defined as a Software as a Medical Device (SaMD); it will be used in combination with an electroretinogram (ERG). This study will be performed using three different ERG devices, currently marketed and cleared by the health authorities (Espion, UTAS and RETeval) to support ...

Phase N/A

5.04 miles

Learn More »

Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression

By the time Alzheimer's Dementia (AD) and related disorders are diagnosed, the brain has sustained substantial insult that limits the efficacy of current treatments. Preventive interventions are urgently needed but the majority of prevention studies require large numbers of participants, long follow-up periods, and frequent study visits. It is not ...

Phase N/A

5.04 miles

Learn More »